Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.

Ichinose, Yukito; Nakai, Yushi; Kudoh, Shoji; Semba, Hiroshi; Yoshida, Susumu; Nukiwa, Toshihiro; Yamamoto, Hidehiko; Yamane, Yoshio; Niitani, Hisanobu

Ichinose, Yukito; Nakai, Yushi; Kudoh, Shoji; Semba, Hiroshi; Yoshida, Susumu; Nukiwa, Toshihiro; Yamamoto, Hidehiko; Yamane, Yoshio; Niitani, Hisanobu.

Affiliation

Ichinose Y; Department of Thoracic Oncology, National Kyusyu Cancer Center, Fukuoka, Japan. yichinos@nk-cc.go.jp

Clin Cancer Res ; 10(13): 4369-73, 2004 Jul 01.

Article in En | MEDLINE | ID: mdl-15240524

Subject(s)

Antimetabolites, Antineoplastic/pharmacology; Antineoplastic Agents/pharmacology; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/radiotherapy; Cisplatin/pharmacology; Lung Neoplasms/drug therapy; Lung Neoplasms/radiotherapy; Radiotherapy; Tegafur/pharmacology; Uracil/pharmacology; Adult; Aged; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Sex Factors; Time Factors; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Radiotherapy / Uracil / Tegafur / Cisplatin / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antimetabolites, Antineoplastic / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links